A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b

Journal of Virological Methods

Volumn 141, Issue 1, 2007, Pages 1-6

  Okamoto, Katsura ^a   Akuta, Norio ^b   Kumada, Hiromitsu ^b   Kobayashi, Mariko ^b   Matsuo, Yuki ^a   Tazawa, Hiromitsu ^a  

^a SRL INC   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

Core region; Hepatitis C virus (HCV); Interferon; Mutant specific primer; Non virological response; Ribavirin; RT PCR

Indexed keywords

HEPATITIS C VIRUS 1B CORE REGION; INTERFERON; PRIMER DNA; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; ELECTROPHORESIS; GENE MUTATION; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS 1B; HUMAN; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; VIRUS DETECTION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; BASE SEQUENCE; DRUG THERAPY, COMBINATION; ELECTROPHORESIS; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RIBAVIRIN; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; VARIATION (GENETICS); VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1;

EID: 33847036713     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2006.11.020     Document Type: Article

References (6)

1. Akuta N., Suzuki F., Sezaki H., Suzuki Y., Hosaka T., Someya T., Kobayashi M., Saitoh S., Watahiki S., Sato J., Matsuda M., Kobayashi M., Arase Y., Ikeda K., and Kumada H. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype1b high viral load and non-virological response to interferon-ribavirin combination therapy. Intervirology 48 (2005) 372-380
2. Akuta N., Suzuki F., Sezaki H., Suzuki Y., Hosaka T., Someya T., Kobayashi M., Saitoh S., Watahiki S., Sato J., Kobayashi M., Arase Y., Ikeda K., and Kumada H. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load. J. Med. Virol. 78 (2006) 83-90
3. Fried M.W., Shiffman M.L., Reddy R., Smith C., Marinos G., Gonçales F.L., Häussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., and Yu J. Peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347 (2002) 975-982
4. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., and Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9524-9528
5. Kwok S., and Higuchi R. Avoiding false positives with PCR. Nature 339 (1989) 237-238
6. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M.H., and Albrecht J.K. Peg-interferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358 (2001) 958-965